Author： Mortimer Ann M
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.4, 2004-04, pp. : 315-329
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antipsychotics for schizophrenia in children and adolescents
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Access to resources
Recommend
Effects of Antipsychotics on the BDNF in Schizophrenia
Current Medicinal Chemistry, Vol. 20, Iss. 3, 2013-01 ,pp. :
Limitations in the effectiveness of antipsychotics in schizophrenia
Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. :
Conventional antipsychotics reduce rehospitalisation in schizophrenia
Inpharma, Vol. 1, Iss. 1350, 2002-01 ,pp. :
Dose Response and Atypical Antipsychotics in Schizophrenia
By Kinon B.J.
CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. :